- IBDEI21B ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,32473,1,4,0)
- ;;=4^H35.041
- ;;^UTILITY(U,$J,358.3,32473,2)
- ;;=^5005594
- ;;^UTILITY(U,$J,358.3,32474,0)
- ;;=H35.042^^128^1661^29
- ;;^UTILITY(U,$J,358.3,32474,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32474,1,3,0)
- ;;=3^Retinal Micro-Aneurysms,Unspec,OS
- ;;^UTILITY(U,$J,358.3,32474,1,4,0)
- ;;=4^H35.042
- ;;^UTILITY(U,$J,358.3,32474,2)
- ;;=^5005595
- ;;^UTILITY(U,$J,358.3,32475,0)
- ;;=H35.053^^128^1661^33
- ;;^UTILITY(U,$J,358.3,32475,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32475,1,3,0)
- ;;=3^Retinal Neovascularization,Unspec,OU
- ;;^UTILITY(U,$J,358.3,32475,1,4,0)
- ;;=4^H35.053
- ;;^UTILITY(U,$J,358.3,32475,2)
- ;;=^5005600
- ;;^UTILITY(U,$J,358.3,32476,0)
- ;;=H35.051^^128^1661^31
- ;;^UTILITY(U,$J,358.3,32476,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32476,1,3,0)
- ;;=3^Retinal Neovascularization,Unspec,OD
- ;;^UTILITY(U,$J,358.3,32476,1,4,0)
- ;;=4^H35.051
- ;;^UTILITY(U,$J,358.3,32476,2)
- ;;=^5005598
- ;;^UTILITY(U,$J,358.3,32477,0)
- ;;=H35.052^^128^1661^32
- ;;^UTILITY(U,$J,358.3,32477,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32477,1,3,0)
- ;;=3^Retinal Neovascularization,Unspec,OS
- ;;^UTILITY(U,$J,358.3,32477,1,4,0)
- ;;=4^H35.052
- ;;^UTILITY(U,$J,358.3,32477,2)
- ;;=^5005599
- ;;^UTILITY(U,$J,358.3,32478,0)
- ;;=H35.073^^128^1661^36
- ;;^UTILITY(U,$J,358.3,32478,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32478,1,3,0)
- ;;=3^Retinal Telangiectasis,OU
- ;;^UTILITY(U,$J,358.3,32478,1,4,0)
- ;;=4^H35.073
- ;;^UTILITY(U,$J,358.3,32478,2)
- ;;=^5005608
- ;;^UTILITY(U,$J,358.3,32479,0)
- ;;=H35.071^^128^1661^34
- ;;^UTILITY(U,$J,358.3,32479,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32479,1,3,0)
- ;;=3^Retinal Telangiectasis,OD
- ;;^UTILITY(U,$J,358.3,32479,1,4,0)
- ;;=4^H35.071
- ;;^UTILITY(U,$J,358.3,32479,2)
- ;;=^5005606
- ;;^UTILITY(U,$J,358.3,32480,0)
- ;;=H35.072^^128^1661^35
- ;;^UTILITY(U,$J,358.3,32480,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32480,1,3,0)
- ;;=3^Retinal Telangiectasis,OS
- ;;^UTILITY(U,$J,358.3,32480,1,4,0)
- ;;=4^H35.072
- ;;^UTILITY(U,$J,358.3,32480,2)
- ;;=^5005607
- ;;^UTILITY(U,$J,358.3,32481,0)
- ;;=H34.03^^128^1661^23
- ;;^UTILITY(U,$J,358.3,32481,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32481,1,3,0)
- ;;=3^Transient Retinal Artery Occlusion,OU
- ;;^UTILITY(U,$J,358.3,32481,1,4,0)
- ;;=4^H34.03
- ;;^UTILITY(U,$J,358.3,32481,2)
- ;;=^5005555
- ;;^UTILITY(U,$J,358.3,32482,0)
- ;;=H34.01^^128^1661^21
- ;;^UTILITY(U,$J,358.3,32482,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32482,1,3,0)
- ;;=3^Transient Retinal Artery Occlusion,OD
- ;;^UTILITY(U,$J,358.3,32482,1,4,0)
- ;;=4^H34.01
- ;;^UTILITY(U,$J,358.3,32482,2)
- ;;=^5005553
- ;;^UTILITY(U,$J,358.3,32483,0)
- ;;=H34.02^^128^1661^22
- ;;^UTILITY(U,$J,358.3,32483,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32483,1,3,0)
- ;;=3^Transient Retinal Artery Occlusion,OS
- ;;^UTILITY(U,$J,358.3,32483,1,4,0)
- ;;=4^H34.02
- ;;^UTILITY(U,$J,358.3,32483,2)
- ;;=^5005554
- ;;^UTILITY(U,$J,358.3,32484,0)
- ;;=H35.00^^128^1661^47
- ;;^UTILITY(U,$J,358.3,32484,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32484,1,3,0)
- ;;=3^Background Retinopathy,Unspec
- ;;^UTILITY(U,$J,358.3,32484,1,4,0)
- ;;=4^H35.00
- ;;^UTILITY(U,$J,358.3,32484,2)
- ;;=^5005581
- ;;^UTILITY(U,$J,358.3,32485,0)
- ;;=H34.823^^128^1661^50
- ;;^UTILITY(U,$J,358.3,32485,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32485,1,3,0)
- ;;=3^Venous Engorgement,OU
- ;;^UTILITY(U,$J,358.3,32485,1,4,0)
- ;;=4^H34.823
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI21B 3761 printed Mar 13, 2025@21:24:41 Page 2
- IBDEI21B ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,32473,1,4,0)
- +2 ;;=4^H35.041
- +3 ;;^UTILITY(U,$J,358.3,32473,2)
- +4 ;;=^5005594
- +5 ;;^UTILITY(U,$J,358.3,32474,0)
- +6 ;;=H35.042^^128^1661^29
- +7 ;;^UTILITY(U,$J,358.3,32474,1,0)
- +8 ;;=^358.31IA^4^2
- +9 ;;^UTILITY(U,$J,358.3,32474,1,3,0)
- +10 ;;=3^Retinal Micro-Aneurysms,Unspec,OS
- +11 ;;^UTILITY(U,$J,358.3,32474,1,4,0)
- +12 ;;=4^H35.042
- +13 ;;^UTILITY(U,$J,358.3,32474,2)
- +14 ;;=^5005595
- +15 ;;^UTILITY(U,$J,358.3,32475,0)
- +16 ;;=H35.053^^128^1661^33
- +17 ;;^UTILITY(U,$J,358.3,32475,1,0)
- +18 ;;=^358.31IA^4^2
- +19 ;;^UTILITY(U,$J,358.3,32475,1,3,0)
- +20 ;;=3^Retinal Neovascularization,Unspec,OU
- +21 ;;^UTILITY(U,$J,358.3,32475,1,4,0)
- +22 ;;=4^H35.053
- +23 ;;^UTILITY(U,$J,358.3,32475,2)
- +24 ;;=^5005600
- +25 ;;^UTILITY(U,$J,358.3,32476,0)
- +26 ;;=H35.051^^128^1661^31
- +27 ;;^UTILITY(U,$J,358.3,32476,1,0)
- +28 ;;=^358.31IA^4^2
- +29 ;;^UTILITY(U,$J,358.3,32476,1,3,0)
- +30 ;;=3^Retinal Neovascularization,Unspec,OD
- +31 ;;^UTILITY(U,$J,358.3,32476,1,4,0)
- +32 ;;=4^H35.051
- +33 ;;^UTILITY(U,$J,358.3,32476,2)
- +34 ;;=^5005598
- +35 ;;^UTILITY(U,$J,358.3,32477,0)
- +36 ;;=H35.052^^128^1661^32
- +37 ;;^UTILITY(U,$J,358.3,32477,1,0)
- +38 ;;=^358.31IA^4^2
- +39 ;;^UTILITY(U,$J,358.3,32477,1,3,0)
- +40 ;;=3^Retinal Neovascularization,Unspec,OS
- +41 ;;^UTILITY(U,$J,358.3,32477,1,4,0)
- +42 ;;=4^H35.052
- +43 ;;^UTILITY(U,$J,358.3,32477,2)
- +44 ;;=^5005599
- +45 ;;^UTILITY(U,$J,358.3,32478,0)
- +46 ;;=H35.073^^128^1661^36
- +47 ;;^UTILITY(U,$J,358.3,32478,1,0)
- +48 ;;=^358.31IA^4^2
- +49 ;;^UTILITY(U,$J,358.3,32478,1,3,0)
- +50 ;;=3^Retinal Telangiectasis,OU
- +51 ;;^UTILITY(U,$J,358.3,32478,1,4,0)
- +52 ;;=4^H35.073
- +53 ;;^UTILITY(U,$J,358.3,32478,2)
- +54 ;;=^5005608
- +55 ;;^UTILITY(U,$J,358.3,32479,0)
- +56 ;;=H35.071^^128^1661^34
- +57 ;;^UTILITY(U,$J,358.3,32479,1,0)
- +58 ;;=^358.31IA^4^2
- +59 ;;^UTILITY(U,$J,358.3,32479,1,3,0)
- +60 ;;=3^Retinal Telangiectasis,OD
- +61 ;;^UTILITY(U,$J,358.3,32479,1,4,0)
- +62 ;;=4^H35.071
- +63 ;;^UTILITY(U,$J,358.3,32479,2)
- +64 ;;=^5005606
- +65 ;;^UTILITY(U,$J,358.3,32480,0)
- +66 ;;=H35.072^^128^1661^35
- +67 ;;^UTILITY(U,$J,358.3,32480,1,0)
- +68 ;;=^358.31IA^4^2
- +69 ;;^UTILITY(U,$J,358.3,32480,1,3,0)
- +70 ;;=3^Retinal Telangiectasis,OS
- +71 ;;^UTILITY(U,$J,358.3,32480,1,4,0)
- +72 ;;=4^H35.072
- +73 ;;^UTILITY(U,$J,358.3,32480,2)
- +74 ;;=^5005607
- +75 ;;^UTILITY(U,$J,358.3,32481,0)
- +76 ;;=H34.03^^128^1661^23
- +77 ;;^UTILITY(U,$J,358.3,32481,1,0)
- +78 ;;=^358.31IA^4^2
- +79 ;;^UTILITY(U,$J,358.3,32481,1,3,0)
- +80 ;;=3^Transient Retinal Artery Occlusion,OU
- +81 ;;^UTILITY(U,$J,358.3,32481,1,4,0)
- +82 ;;=4^H34.03
- +83 ;;^UTILITY(U,$J,358.3,32481,2)
- +84 ;;=^5005555
- +85 ;;^UTILITY(U,$J,358.3,32482,0)
- +86 ;;=H34.01^^128^1661^21
- +87 ;;^UTILITY(U,$J,358.3,32482,1,0)
- +88 ;;=^358.31IA^4^2
- +89 ;;^UTILITY(U,$J,358.3,32482,1,3,0)
- +90 ;;=3^Transient Retinal Artery Occlusion,OD
- +91 ;;^UTILITY(U,$J,358.3,32482,1,4,0)
- +92 ;;=4^H34.01
- +93 ;;^UTILITY(U,$J,358.3,32482,2)
- +94 ;;=^5005553
- +95 ;;^UTILITY(U,$J,358.3,32483,0)
- +96 ;;=H34.02^^128^1661^22
- +97 ;;^UTILITY(U,$J,358.3,32483,1,0)
- +98 ;;=^358.31IA^4^2
- +99 ;;^UTILITY(U,$J,358.3,32483,1,3,0)
- +100 ;;=3^Transient Retinal Artery Occlusion,OS
- +101 ;;^UTILITY(U,$J,358.3,32483,1,4,0)
- +102 ;;=4^H34.02
- +103 ;;^UTILITY(U,$J,358.3,32483,2)
- +104 ;;=^5005554
- +105 ;;^UTILITY(U,$J,358.3,32484,0)
- +106 ;;=H35.00^^128^1661^47
- +107 ;;^UTILITY(U,$J,358.3,32484,1,0)
- +108 ;;=^358.31IA^4^2
- +109 ;;^UTILITY(U,$J,358.3,32484,1,3,0)
- +110 ;;=3^Background Retinopathy,Unspec
- +111 ;;^UTILITY(U,$J,358.3,32484,1,4,0)
- +112 ;;=4^H35.00
- +113 ;;^UTILITY(U,$J,358.3,32484,2)
- +114 ;;=^5005581
- +115 ;;^UTILITY(U,$J,358.3,32485,0)
- +116 ;;=H34.823^^128^1661^50
- +117 ;;^UTILITY(U,$J,358.3,32485,1,0)
- +118 ;;=^358.31IA^4^2
- +119 ;;^UTILITY(U,$J,358.3,32485,1,3,0)
- +120 ;;=3^Venous Engorgement,OU
- +121 ;;^UTILITY(U,$J,358.3,32485,1,4,0)
- +122 ;;=4^H34.823
